title: Mono-(2-ethylhexyl) phthalate directly alters the expression of Leydig cell genes and CYP17 lyase activity in cultured rat fetal testis.
abstract: Exposure to phthalates in utero alters fetal rat testis gene expression and testosterone production, but much remains to be done to understand the mechanisms underlying the direct action of phthalate within the fetal testis. We aimed to investigate the direct mechanisms of action of mono-(2-ethylhexyl) phthalate (MEHP) on the rat fetal testis, focusing on Leydig cell steroidogenesis in particular. We used an in vitro system based on the culture for three days, with or without MEHP, of rat fetal testes obtained at 14.5 days post-coitum.Exposure to MEHP led to a dose-dependent decrease in testosterone production. Moreover, the production of 5 alpha-dihydrotestosterone (5α-DHT) (-68%) and androstenedione (-54%) was also inhibited by 10 µM MEHP, whereas 17 alpha-hydroxyprogesterone (17α-OHP) production was found to increase (+41%). Testosterone synthesis was rescued by the addition of androstenedione but not by any of the other precursors used. Thus, the hormone data suggested that steroidogenesis was blocked at the level of the 17,20 lyase activity of the P450c17 enzyme (CYP17), converting 17α-OHP to androstenedione. The subsequent gene expression and protein levels supported this hypothesis. In addition to Cyp17a1, microarray analysis showed that several other genes important for testes development were affected by MEHP. These genes included those encoding insulin-like factor 3 (INSL3), which is involved in controlling testicular descent, and Inha, which encodes the alpha subunit of inhibin B.These findings indicate that under in vitro conditions known to support normal differentiation of the fetal rat testis, the exposure to MEHP directly inhibits several important Leydig cell factors involved in testis function and that the Cyp17a1 gene is a specific target to MEHP explaining the MEHP-induced suppression of steroidogenesis observed.
authors.affiliation: Institut National de la Santé et de la Recherche Médicale, U625, Rennes, France.
authors.forename: François
authors.initials: F
authors.lastname: Chauvigné
authors.forename: Simon
authors.initials: S
authors.lastname: Plummer
authors.forename: Laurianne
authors.initials: L
authors.lastname: Lesné
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Cravedi
authors.forename: Nathalie
authors.initials: N
authors.lastname: Dejucq-Rainsford
authors.forename: Alexis
authors.initials: A
authors.lastname: Fostier
authors.forename: Bernard
authors.initials: B
authors.lastname: Jégou
mesh_terms: D019326:17-alpha-Hydroxyprogesterone / Q000378:metabolism; D000818:Animals; D002478:Cells, Cultured; D004051:Diethylhexyl Phthalate / Q000031:analogs & derivatives* / Q000494:pharmacology; D013196:Dihydrotestosterone / Q000378:metabolism; D005333:Fetus / Q000473:pathology; D005786:Gene Expression Regulation / Q000187:drug effects*; D007985:Leydig Cells / Q000187:drug effects* / Q000378:metabolism; D008190:Lyases / Q000378:metabolism*; D008297:Male; D051381:Rats; D013254:Steroid 17-alpha-Hydroxylase / Q000378:metabolism*; D013256:Steroids / Q000096:biosynthesis; D013737:Testis / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D013739:Testosterone / Q000096:biosynthesis
chemical_list: D013256:Steroids; D013196:Dihydrotestosterone; D013739:Testosterone; D019326:17-alpha-Hydroxyprogesterone; D004051:Diethylhexyl Phthalate; D013254:Steroid 17-alpha-Hydroxylase; D008190:Lyases; C016599:mono-(2-ethylhexyl)phthalate
references.citation: Fertil Steril. 2008 Feb;89(2 Suppl):e33-8
references.pmid: 18308057
references.citation: Toxicol Sci. 2000 Dec;58(2):339-49
references.pmid: 11099646
references.citation: Prostate. 2000 May 15;43(3):195-204
references.pmid: 10797494
references.citation: Reprod Toxicol. 2002 Jan-Feb;16(1):19-28
references.pmid: 11934529
references.citation: Reprod Toxicol. 2008 Aug;25(4):485-90
references.pmid: 18583092
references.citation: Nat Genet. 1999 Jul;22(3):295-9
references.pmid: 10391220
references.citation: Environ Health Perspect. 2009 Apr;117(4):515-21
references.pmid: 19440488
references.citation: Toxicol Sci. 2006 Oct;93(2):369-81
references.pmid: 16809437
references.citation: Toxicol Sci. 2001 Dec;64(2):233-42
references.pmid: 11719706
references.citation: Biol Reprod. 2007 Dec;77(6):978-89
references.pmid: 17881770
references.citation: Birth Defects Res B Dev Reprod Toxicol. 2005 Jun;74(3):277-85
references.pmid: 15954088
references.citation: Talanta. 2009 Dec 15;80(2):826-32
references.pmid: 19836559
references.citation: Endocrinology. 2008 Oct;149(10):5280-7
references.pmid: 18566125
references.citation: Hum Reprod Update. 2001 May-Jun;7(3):231-5
references.pmid: 11392369
references.citation: J Biol Chem. 2005 Apr 8;280(14):13265-71
references.pmid: 15687493
references.citation: Mol Cell Biochem. 2000 Oct;213(1-2):51-9
references.pmid: 11129958
references.citation: Reprod Fertil Dev. 2001;13(7-8):673-8
references.pmid: 11999320
references.citation: Toxicol In Vitro. 2010 Feb;24(1):327-34
references.pmid: 19699292
references.citation: Fish Physiol Biochem. 1986 Oct;2(1-4):87-99
references.pmid: 24233170
references.citation: Toxicol Sci. 2004 Sep;81(1):60-8
references.pmid: 15141095
references.citation: Endocrinology. 2004 Mar;145(3):1227-37
references.pmid: 14617579
references.citation: J Lipid Res. 1993 Jun;34(6):867-74
references.pmid: 8102635
references.citation: Hum Reprod Update. 2001 May-Jun;7(3):248-64
references.pmid: 11392371
references.citation: Toxicol Sci. 2000 Dec;58(2):350-65
references.pmid: 11099647
references.citation: Toxicol Lett. 2007 Sep 10;173(2):107-17
references.pmid: 17698303
references.citation: Reprod Toxicol. 2006 Oct;22(3):291-399
references.pmid: 17068859
references.citation: Environ Health Perspect. 2006 Nov;114(11):1643-8
references.pmid: 17107847
references.citation: Endocrinology. 2010 Jul;151(7):3348-62
references.pmid: 20463053
references.citation: Endocrinology. 2008 Sep;149(9):4688-94
references.pmid: 18499751
references.citation: Toxicol Sci. 2003 May;73(1):160-9
references.pmid: 12657744
references.citation: J Clin Invest. 2008 Apr;118(4):1479-90
references.pmid: 18340380
references.citation: Environ Health Perspect. 1996 Aug;104 Suppl 4:741-803
references.pmid: 8880001
references.citation: J Lipid Res. 1998 Dec;39(12):2406-14
references.pmid: 9831628
references.citation: Mol Endocrinol. 1999 May;13(5):681-91
references.pmid: 10319319
references.citation: Toxicol Sci. 2007 Jun;97(2):520-32
references.pmid: 17379624
references.citation: Mol Cell Endocrinol. 1991 Dec;82(2-3):199-206
references.pmid: 1794610
references.citation: J Biol Chem. 2001 Sep 28;276(39):36225-32
references.pmid: 11459837
references.citation: Biol Reprod. 2005 Jul;73(1):180-92
references.pmid: 15728792
references.citation: Toxicol Sci. 2007 Sep;99(1):190-202
references.pmid: 17400582
references.citation: Int J Androl. 2006 Feb;29(1):140-7; discussion 181-5
references.pmid: 16102138
references.citation: Endocrinology. 2005 Oct;146(10):4536-44
references.pmid: 16037377
references.citation: J Androl. 2009 May-Jun;30(3):287-97
references.pmid: 19059903
references.citation: Environ Health Perspect. 2005 Aug;113(8):1056-61
references.pmid: 16079079
references.citation: Endocrinology. 1997 May;138(5):2136-47
references.pmid: 9112414
references.citation: Biochem J. 2001 Feb 1;353(Pt 3):689-99
references.pmid: 11171067
references.citation: Toxicol Sci. 2007 May;97(1):81-93
references.pmid: 17311803
references.citation: Steroids. 1997 Jan;62(1):133-42
references.pmid: 9029728
references.citation: Environ Health Perspect. 2006 Feb;114(2):270-6
references.pmid: 16451866
references.citation: Trends Endocrinol Metab. 2009 Apr;20(3):139-45
references.pmid: 19278865
references.citation: Endocr Rev. 2009 Dec;30(7):883-925
references.pmid: 19887492
references.citation: Toxicol Sci. 2002 Oct;69(2):344-53
references.pmid: 12377983